Expon Capital

Expon Capital is a Luxembourg-based venture capital firm and global investor that backs companies with potential for positive impact and exponential growth. It focuses on technology-driven sectors, including cybersecurity, fintech and regtech, big data, digital health and digital learning, the internet of things, next-generation media and communications networks, satellite-based information and related technologies. The firm targets opportunities across Europe, with a particular emphasis on Luxembourg.

Marc Gendebien

Co-Founder and Managing Partner

Seunghun Park

Investment Analyst

Owen Reynolds

Venture Partner

Alain Rodermann

Co-Founder and Managing Partner

Rodrigo Sepulveda

Managing Partner

Jerome Wittamer

Managing Partner

Past deals in Self-improvement

HelloBetter

Venture Round in 2025
HelloBetter is a digital therapeutics company that develops and delivers evidence‑based online mental‑health programs. Founded in 2015 as a university spin‑off, it offers courses for conditions such as stress, depression, anxiety, panic, insomnia, chronic pain, alcohol use, and diabetes‑related mood disorders. The platform is approved as a DiGA in Germany, allowing prescription‑based access and nationwide reimbursement for more than 73 million people. Over 30 randomized controlled trials have evaluated its ten programs, making it a global leader in digital mental‑health research. The company operates from Hamburg and Berlin and continues to expand beyond the DACH region.

HelloBetter

Series A in 2023
HelloBetter is a digital therapeutics company that develops and delivers evidence‑based online mental‑health programs. Founded in 2015 as a university spin‑off, it offers courses for conditions such as stress, depression, anxiety, panic, insomnia, chronic pain, alcohol use, and diabetes‑related mood disorders. The platform is approved as a DiGA in Germany, allowing prescription‑based access and nationwide reimbursement for more than 73 million people. Over 30 randomized controlled trials have evaluated its ten programs, making it a global leader in digital mental‑health research. The company operates from Hamburg and Berlin and continues to expand beyond the DACH region.

HelloBetter

Series A in 2022
HelloBetter is a digital therapeutics company that develops and delivers evidence‑based online mental‑health programs. Founded in 2015 as a university spin‑off, it offers courses for conditions such as stress, depression, anxiety, panic, insomnia, chronic pain, alcohol use, and diabetes‑related mood disorders. The platform is approved as a DiGA in Germany, allowing prescription‑based access and nationwide reimbursement for more than 73 million people. Over 30 randomized controlled trials have evaluated its ten programs, making it a global leader in digital mental‑health research. The company operates from Hamburg and Berlin and continues to expand beyond the DACH region.

HelloBetter

Seed Round in 2021
HelloBetter is a digital therapeutics company that develops and delivers evidence‑based online mental‑health programs. Founded in 2015 as a university spin‑off, it offers courses for conditions such as stress, depression, anxiety, panic, insomnia, chronic pain, alcohol use, and diabetes‑related mood disorders. The platform is approved as a DiGA in Germany, allowing prescription‑based access and nationwide reimbursement for more than 73 million people. Over 30 randomized controlled trials have evaluated its ten programs, making it a global leader in digital mental‑health research. The company operates from Hamburg and Berlin and continues to expand beyond the DACH region.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.